364 related articles for article (PubMed ID: 9482902)
1. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
Zhang S; Ramsay ES; Mock BA
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2429-34. PubMed ID: 9482902
[TBL] [Abstract][Full Text] [Related]
2. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
[TBL] [Abstract][Full Text] [Related]
3. p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB.
Zhang S; Qian X; Redman C; Bliskovski V; Ramsay ES; Lowy DR; Mock BA
Oncogene; 2003 Apr; 22(15):2285-95. PubMed ID: 12700664
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
5. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
[TBL] [Abstract][Full Text] [Related]
6. Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.
Bliskovsky V; Ramsay ES; Scott J; DuBois W; Shi W; Zhang S; Qian X; Lowy DR; Mock BA
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14982-7. PubMed ID: 14634209
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
Kawamata N; Miller CW; Koeffler HP
Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
[TBL] [Abstract][Full Text] [Related]
9. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
Potter M; Mushinski EB; Wax JS; Hartley J; Mock BA
Cancer Res; 1994 Feb; 54(4):969-75. PubMed ID: 8313388
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M
Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
13. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
14. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.
Suzuki H; Zhou X; Yin J; Lei J; Jiang HY; Suzuki Y; Chan T; Hannon GJ; Mergner WJ; Abraham JM
Hum Mol Genet; 1995 Oct; 4(10):1883-7. PubMed ID: 8595411
[TBL] [Abstract][Full Text] [Related]
15. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
Gilley J; Fried M
Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
[TBL] [Abstract][Full Text] [Related]
19. An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15INK4b and p16INK4a tumor suppressor genes.
Malumbres M; Pérez de Castro I; Santos J; Pérez-Ollé R; Fernández-Piqueras J; Pellicer A
Mamm Genome; 1998 Mar; 9(3):183-5. PubMed ID: 9501299
[TBL] [Abstract][Full Text] [Related]
20. Translation of p15.5INK4B, an N-terminally extended and fully active form of p15INK4B, is initiated from an upstream GUG codon.
Fuxe J; Raschperger E; Pettersson RF
Oncogene; 2000 Mar; 19(13):1724-8. PubMed ID: 10763830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
